2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis

In Vitro and In Vivo Characterization of 2-Deoxy-2-18F-Fluoro-D-Mannose as a Tumor-Imaging Agent for PET

(2013) S. Furumoto et al.   JOURNAL OF NUCLEAR MEDICINE

Histopathologic Characteristics of Atherosclerotic Coronary Disease and Implications of the Findings for the Invasive and Noninvasive Detection of Vulnerable Plaques

(2013) Jagat Narula et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Omnipresent Atherosclerotic Disease: Time to Depart From Analysis of Individual Vascular Beds

(2012) Fumiyuki Otsuka et al.   MOUNT SINAI JOURNAL OF MEDICINE

Hemoglobin Directs Macrophage Differentiation and Prevents Foam Cell Formation in Human Atherosclerotic Plaques

(2011) Aloke V. Finn et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

(2011) Zahi A Fayad et al.   LANCET

Imaging Atherosclerotic Plaque Inflammation by Fluorodeoxyglucose With Positron Emission Tomography

(2010) James H.F. Rudd et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Feasibility of FDG Imaging of the Coronary Arteries

(2010) Ian S. Rogers et al.   JACC-Cardiovascular Imaging

Arithmetic of vulnerable plaques for noninvasive imaging

(2008) Jagat Narula et al.   Nature clinical practice. Cardiovascular medicine